FDA Publishes Comparative Performance Data for Covid-19 Molecular Diagnostics
The tables show the Limit of Detection of more than 55 authorized molecular diagnostic covid-19 tests against a standardized sample panel provided by the FDA.
Read MorePosted by Melanie Hamilton-Basich | Sep 16, 2020 | Covid 19, Molecular Diagnostics |
The tables show the Limit of Detection of more than 55 authorized molecular diagnostic covid-19 tests against a standardized sample panel provided by the FDA.
Read MorePosted by Melanie Hamilton-Basich | Sep 14, 2020 | Covid 19, Rapid Assays |
The covid-19 tests are the first purchase from a multistate compact created last month to hasten development of quick-result tests.
Read MorePosted by Melanie Hamilton-Basich | Sep 14, 2020 | Covid 19, POC Rapid Assays |
Two versions of the covid-19 Antigen Test are scheduled for US launch in the fourth quarter: one for labs and one for point-of-care use.
Read MorePosted by Melanie Hamilton-Basich | Sep 14, 2020 | Digital Imaging, Information Technology |
The CytoSmart Multi Lux lets researchers carry out side-by-side comparisons between cell cultures, run long-term experiments, and monitor cells from home.
Read MorePosted by Melanie Hamilton-Basich | Sep 13, 2020 | Company News, Covid 19, Lab Essentials |
Enzo has expanded reagent and supply manufacturing and doubled its molecular laboratory testing capacity at its facilities in New York.
Read More